Oligodendrocytic polyglutamine pathology in dentatorubral-pallidoluysian atrophy

Annals of Neurology

Volumn 52, Issue 5, 2002, Pages 670-674

  Yamada, Mitsunori ^a   Sato, Toshiya ^a   Tsuji, Shoji ^a   Takahashi, Hitoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLUTAMINE;

ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL COUNT; CELL NUCLEUS INCLUSION BODY; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GLIA CELL; HUMAN; HUMAN TISSUE; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; WHITE MATTER;

ADULT; AGED; ANIMALS; BRAIN; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MYOCLONIC EPILEPSIES, PROGRESSIVE; OLIGODENDROGLIA; PEPTIDES;

EID: 0036828875     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10352     Document Type: Article

References (19)

1. Naito H, Oyanagi S. Familial myoclonus epilepsy and choreoathetosis: Hereditary dentatorubral-pallidoluysian atrophy. Neurology 1982;32:798-807.
2. Ross CA. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 1995;15:493-496.
3. Tsuji S. Unstable expansion of triplet repeats as a new disease mechanism for neurodegenerative diseases. Jpn J Hum Genet 1996;41:279-290.
4. Takahashi H, Ohama E, Naito H, et al. Hereditary dentatorubral-pallidoluysian atrophy: Clinical and pathologic variants in a family. Neurology 1988;38:1065-1070.
5. Takeda S, Takahashi H. Neuropathology of dentatorubropallidoluysian atrophy. Neuropathology 1996;16:48-55.
6. Mizoi Y, Segawa F, Kamada K, et al. Investigation of involvement of cerebral white matter in DRPLA - Including MRI perfusion study (in Japanese with English abstract). No to Shinkei 1994;46:145-151.
7. Koide R, Onodera O, Ikeuchi T, et al. Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings. Neurology 1997;49:1605-1612.
8. Naito H. Progressive myoclonus epilepsy and DRPLA (in Japanese with English abstract). Shinkei Kenkyu No Shimpo 1990;34:56-67.
9. Sato T, Oyake M, Nakamura K, et al. Transgenic mice harboring a fall-length human mutant DRPLA gene exhibit agedependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Hum Mol Genet 1999;8:99-106.
10. Sato T, Yamada M, Oyake M, et al. Transgenic mice harboring a full-length human DRPLA gene with highly expanded CAG repeats exhibit severe disease phenotype. Am J Hum Genet 1999;65(suppl):A30.
11. Yamada M, Wood JD, Shimohata T, et al. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy. Ann Neurol 2001;49:14-23.
12. Morris CM, Candy JM, Bloxham CA, Edwardson JA. Immunocytochemical localization of transferrin in the human brain. Acta Anat 1992;143:14-18.
13. Takano H, Onodera O, Takahashi H, et al. Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: Cellular population-dependent dynamics of mitotic instability. Am J Hum Genet 1996;58:1212-1222.
14. Yamada M, Tsuji S, Takahashi H. Pathology of CAG repeat diseases. Neuropathology 2000;20:319-325.
15. Yamada M, Hayashi S, Tsuji S, Takahashi H. Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease. Acta Neuropathol 2001;101:140-144.
16. Schilling G, Wood JD, Duan K, et al. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Neuron 1999;24:275-286.
17. Davies SW, Turmaine M, Cozens BA, et al. From neuronal inclusions to neurodegeneration: Neuropathological investigation of a transgenic mouse model of Huntington's disease. Philos Trans R Soc Lond B Biol Sci 1999;354:981-989.
18. Shimohata T, Nakajima T, Yamada M, et al. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet 2000;26:29-36.
19. Nucifora FC Jr, Sasaki M, Peters MF, et al. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 2001;291:2423-2428.